WUXI BIO (02269) has a current Price-to-Book (P/B) ratio of 2.72. Compared to its 3-year average P/B ratio of 2.68, the current P/B ratio is approximately 1.79% higher. Relative to its 5-year average P/B ratio of 5.31, the current P/B ratio is about -48.76% higher. WUXI BIO (02269) has a Forward Free Cash Flow (FCF) yield of approximately 1.46%. Compared to its 3-year average FCF yield of 0.64%, the current FCF yield is approximately 127.58% lower. Relative to its 5-year average FCF yield of 0.03%, the current FCF yield is about 4502.17% lower.

Performance Decomposition

AI Analysis

Market capitalization of 02269 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 02269 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 02269 currently overvalued or undervalued?

What is WUXI BIO (02269) fair value?

02269's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of WUXI BIO (02269) is between to according to relative valuation method.

How does 02269's valuation metrics compare to the industry average?

The average P/S ratio for 02269's competitors is 0.00, providing a benchmark for relative valuation. WUXI BIO Corp (02269) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for WUXI BIO (02269) as of Mar 02 2026?

As of Mar 02 2026, WUXI BIO (02269) has a P/B ratio of 2.72. This indicates that the market values 02269 at 2.72 times its book value.

What is the current FCF Yield for WUXI BIO (02269) as of Mar 02 2026?

As of Mar 02 2026, WUXI BIO (02269) has a FCF Yield of 1.46%. This means that for every dollar of WUXI BIO's market capitalization, the company generates 1.46 cents in free cash flow.

What is the current Forward P/E ratio for WUXI BIO (02269) as of Mar 02 2026?

As of Mar 02 2026, WUXI BIO (02269) has a Forward P/E ratio of 24.00. This means the market is willing to pay $24.00 for every dollar of WUXI BIO's expected earnings over the next 12 months.

What is the current Forward P/S ratio for WUXI BIO (02269) as of Mar 02 2026?

As of Mar 02 2026, WUXI BIO (02269) has a Forward P/S ratio of 5.20. This means the market is valuing 02269 at $5.20 for every dollar of expected revenue over the next 12 months.

02269 Valuation